Release
📈 Stocks
AnnJi Pharmaceutical Advances AJ201 to Phase 3 Trial for SBMA Treatment
(39 minutes ago)
AnnJi Pharmaceutical initiates Phase 3 testing for AJ201, the only clinical-stage oral therapy currently in development for spinal and bulbar muscular atrophy…